Impact of the COVID-19 pandemic on diabetic ketoacidosis management in the pediatric intensive care unit
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Diabetic ketoacidosis (DKA) is a common endocrine emergency in pediatric patients. Early presentation to health facilities, diagnosis, and good management in the pediatric intensive care unit (PICU) are crucial for better outcomes in children with DKA. Methods: This was a single-center, retrospective cohort study conducted between February 2015 and January 2022. Patients with DKA were divided into two groups according to pandemic status and diabetes diagnosis. Both groups were examined in two subcategories (pandemic status: pre-pandemic vs. pandemic; and diabetes diagnosis status: previously diagnosed vs. newly diagnosed).Results: The study enrolled 59 patients, and their mean age was 11±5 years. Forty (68%) had newly diagnosed type 1 diabetes mellitus (T1DM), and 61% received follow-up in the pre-pandemic period. Blood glucose, blood ketone, potassium, phosphorus, creatinine, and alanine transaminase levels were significantly higher in the new-onset T1DM group compared with the previously diagnosed group (P=0.01, P=0.02, P=0.01, P=0.039, and p=0.001, respectively). In patients with newly diagnosed T1DM, length of PICU stays were longer than in those with previously diagnosed T1DM (28.5±8.9 vs. 17.3±6.7 hours, p<0.005). The pandemic group was compared with pre-pandemic group, there was a statistically significant difference in laboratory parameters of pH, HCO3, and lactate and also Pediatric Risk Of Mortality (PRISM) III score. All patients survived, and there were no neurologic sequelae. Conclusion: Patients admitted during the pandemic period were admitted with more severe DKA and had higher PRISM III scores. During the pandemic period, there was an increase in the incidence of DKA in the participating center compared to that before the pandemic. Although the reason for this is not fully known, it could be public health presentations were not effective during the coronavirus disease 2019 (COVID-19) period.
Abstract
Background: Diabetic ketoacidosis (DKA) is a common endocrine emergency in pediatric patients. Early presentation to health facilities, diagnosis, and good management in the pediatric intensive care unit (PICU) are crucial for better outcomes in children with DKA. Methods: This was a single-center, retrospective cohort study conducted between February 2015 and January 2022. Patients with DKA were divided into two groups according to pandemic status and diabetes diagnosis. Both groups were examined in two subcategories (pandemic status: pre-pandemic vs. pandemic; and diabetes diagnosis status: previously diagnosed vs. newly diagnosed).Results: The study enrolled 59 patients, and their mean age was 11±5 years. Forty (68%) had newly diagnosed type 1 diabetes mellitus (T1DM), and 61% received follow-up in the pre-pandemic period. Blood glucose, blood ketone, potassium, phosphorus, creatinine, and alanine transaminase levels were significantly higher in the new-onset T1DM group compared with the previously diagnosed group (P=0.01, P=0.02, P=0.01, P=0.039, and p=0.001, respectively). In patients with newly diagnosed T1DM, length of PICU stays were longer than in those with previously diagnosed T1DM (28.5±8.9 vs. 17.3±6.7 hours, p<0.005). The pandemic group was compared with pre-pandemic group, there was a statistically significant difference in laboratory parameters of pH, HCO3, and lactate and also Pediatric Risk Of Mortality (PRISM) III score. All patients survived, and there were no neurologic sequelae. Conclusion: Patients admitted during the pandemic period were admitted with more severe DKA and had higher PRISM III scores. During the pandemic period, there was an increase in the incidence of DKA in the participating center compared to that before the pandemic. Although the reason for this is not fully known, it could be public health presentations were not effective during the coronavirus disease 2019 (COVID-19) period.
참고문헌 (22)
- von Saint Andre-von Arnim A, "Common endocrine issues in the pediatric intensive care unit", Crit Care Clin, 29, pp.335~358 (2013)
- Sherry NA, "Management of diabetic ketoacidosis in children and adolescents", Paediatr Drugs, 10, pp.209~215 (2008)
- Ganesh R, "Diabetic ketoacidosis in children", Natl Med J India, 19, pp.155~158 (2006)
- Jayashree M, "Diabetic ketoacidosis : predictors of outcome in a pediatric intensive care unit of a developing country", Pediatr Crit Care Med, 5, pp.427~433 (2004)
- Wolfsdorf JI, "ISPAD Clinical Practice Consensus Guidelines 2014: diabetic ketoacidosis and hyperglycemic hyperosmolar state", Pediatr Diabetes, 15(Suppl 20), pp.154~179 (2014)
- Castellanos L, "Management of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus", Paediatr Drugs, 22, pp.357~367 (2020)
- Del Pozo P, "Clinical profile of children with diabetic ketoacidosis in fifteen years of management in a Critical Care Unit", Rev Chil Pediatr, 89, pp.491~498 (2018)
- "Child diabetes group diabetic ketoacidosis (DKA) treatment and follow-up guide" (2016)[URL]
- Pollack MM, "PRISM III : an updated Pediatric Risk of Mortality score", Crit Care Med, 24, pp.743~752 (1996)
- Lopes CL, "Diabetic ketoacidosis in a pediatric intensive care unit", J Pediatr(Rio J), 93, pp.179~184 (2017)
- Baloch SH, "Pediatric risk of mortality III score in predicting mortality among diabetic ketoacidosis patients in a pediatric ıntensive care unit", Cureus, 13, pp.e19734~ (2021)
- Alfayez OM, "Incidence of diabetic ketoacidosis among pediatrics with type 1 diabetes prior to and during COVID-19 pandemic : a meta-analysis of observational studies", Front Endocrinol(Lausanne), 13, pp.856958~ (2022)
- Apicella M, "COVID-19 in people with diabetes : understanding the reasons for worse outcomes", Lancet Diabetes Endocrinol, 8, pp.782~792 (2020)
- Chee YJ, "Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus", Diabetes Res Clin Pract, 164, pp.108166~ (2020)
- Li J, "COVID-19 infection may cause ketosis and ketoacidosis", Diabetes Obes Metab, 22, pp.1935~1941 (2020)
- Rubino F, "New-onset diabetes in Covid-19", N Engl J Med, 383, pp.789~790 (2020)
- Glaser N, "Risk factors for cerebral edema in children with diabetic ketoacidosis", N Engl J Med, 344, pp.264~269 (2001)
- Lawrence SE, "Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis", J Pediatr, 146, pp.688~692 (2005)
- Ghetti S, "Cognitive function following diabetic ketoacidosis in children with new-onset or previously diagnosed type 1 diabetes", Diabetes Care, 43, pp.2768~2775 (2020)
- Durward A, "The temporal relationship between glucose-corrected serum sodium and neurological status in severe diabetic ketoacidosis", Arch Dis Child, 96, pp.50~57 (2011)
- Lone SW, "Frequency, clinical characteristics and outcome of diabetic ketoacidosis in children with type-1 diabetes at a tertiary care hospital", J Pak Med Assoc, 60, pp.725~729 (2010)
- Chambers MA, "Increase in the number of pediatric new-onset diabetes and diabetic ketoacidosis cases during the COVID-19 pandemic", Endocr Pract, 28, pp.479~485 (2022)